Authors




Derek Weycker, PhD

Latest:

Benefits and Risks of Live Attenuated Influenza Vaccine in Young Children

Use of live attenuated influenza vaccine in young children has a favorable benefit-risk profile.


Mary Vaughan-Sarrazin, PhD

Latest:

Elderly Veterans With Dual Eligibility for VA and Medicare Services: Where Do They Obtain a Colonoscopy?

This study examines factors impacting the receipt of an outpatient colonoscopy by VA or non-VA providers in older veterans dually eligible for VA/Medicare benefits.




Michael N. Neuss, MD

Latest:

Advancing Performance Measurement in Oncology

The American Society of Clinical Oncology Quality Oncology Practice Initiative has grown to include 973 practices as of 2010. Practices demonstrated rates of end-of-life care and other measures of quality.




Robert W. Dubois, MD

Latest:

The Value of Specialty Pharmaceuticals - A Systematic Review

This study examines whether patients treated with specialty pharmaceuticals have improved outcomes compared with patients treated with conventional therapies, and evaluates costs associated with these treatments.


Roman Buff, MD

Latest:

Frequency of and Harm Associated With Primary Care Safety Incidents

Physicians' and nurses' assessments of the frequency and harm of incidents can be a supplemental method to study patient safety in the primary care office.



Jonathon R. B. Halbesleben, PhD

Latest:

CAH Staff Perceptions of a Clinical Information System Implementation

This study examines staff perceptions of patient care quality and the processes before and after implementation of a comprehensive clinical information system in 7 critical access hospitals.




George Chinhung Linn, MD, PhD

Latest:

Financial Incentives and Use of Cesarean Delivery: Taiwan Birth Data 2003 to 2007

This study explores whether the policies of financial incentives for the demand and supply sides lowered the Cesarean section rate.




Ryan M. Conrad, PhD

Latest:

Do Strict Formularies Replicate Failure for Patients With Schizophrenia?

This study measures the impact of Medicaid formulary restrictions on the rate at which patients who failed on a drug therapy for schizophrenia return to the same therapy.




Thomas M. Maddox, MD, MSc

Latest:

Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.


Mark T. Dransfield, MD

Latest:

Implications of DRG Classification in a Bundled Payment Initiative for COPD

Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.




Peter K. Lindenauer, MD

Latest:

Association Between Length of Stay and Readmission for COPD

Among patients admitted for chronic obstructive pulmonary disease (COPD) at Veterans Affairs hospitals, hospital-level length of stay was not associated with 30-day readmission.


Julie Gazmararian, PhD, MPH

Latest:

Exploring Health Plan Perspectives in Collecting and Using Data on Race, Ethnicity, and Language

In-depth interviews were conducted with 15 health plans to explore why plans collect or forgo race, ethnicity, and language (REL) data collection efforts, and the challenges encountered with collecting and using data for quality improvement.


Fang Xia, PhD

Latest:

Is There a Relationship Between Early Statin Compliance and a Reduction in Healthcare Utilization?

Statin therapy compliance of 80% or higher during the first 2 years of treatment is associated with reduced healthcare resource utilization in the following year.


Jacqueline Vanderpuye-Orgle, PhD

Latest:

Understanding Price Growth in the Market for Targeted Oncology Therapies

The prices of targeted oncology therapies have grown substantially, but revenues have not. This is due in part to large declines in per-drug patient counts.


Kenneth E. Thorpe, PhD

Latest:

Racial Trends in Clinical Preventive Services Use, Chronic Disease Prevalence, and Lack of Insurance Before and After the Affordable Care Act

This paper examines whether the Affordable Care Act reduced the disparities in the use of clinical preventive services, chronic disease prevalence, and the number of uninsured.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo